The abstract is read at the publisher; the summary is JClub's.
In mouse colonization models, ETBF-secreted B. fragilis toxin (BFT) triggers colonic myenteric neuron loss via NOD1-RIPK2-CASP9-CASP3, producing gut dysmotility that persists after ETBF clearance.
- Why it matters: Gut dysmotility after ETBF colonization is a long-term problem, but the mechanism linking bacterial toxin activity to enteric neuron damage and lasting motility dysfunction was unclear.
- What they did: Mice were colonized with ETBF, and BFT-driven neuron apoptosis was mapped to the NOD1-RIPK2-CASP9-CASP3 pathway; human IBD and colorectal cancer cohorts were analyzed for ETBF–Fusobacterium nucleatum abundance correlation.
- The result: F. nucleatum abundance is positively correlated with ETBF in human cohorts, and in mice F. nucleatum-derived 2-hydroxybutyric acid enhances BFT production, worsening neurotoxicity and dysmotility, while a Bifidobacterium-based probiotic attenuates these effects.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.